Abstract
The binding mode of (2S)-2-[4-[[(3S)-1-acetimidoyl-3-pyrrolidinyl]oxy]phenyl]-3-(7-amidino-2-naphthyl)propanoic acid hydrochloride (DX-9065a, 4) to Factor Xa is examined using inhibition data for a series of analogs that have a hydrophobic group as well as basic or dibasic functionality. Comparative molecular field analysis is utilized on a series of DX-9065a analogs in a series of proposed alternative binding modes. A quantitative measure is provided that distinguishes between the proposed binding modes that describes ‘how well’ the binding mode explains the structure-activity relationship or the best 3D QSAR agrees with the crystallographically determined binding mode. The best model is in agreement with recently available data [Brandstetter et al., J. Biol. Chem., 271 (1996) 29988]. The highest statistical correlation occurs with the second basic group accommodated in the vicinity of Glu97 and a hydrophobic group accommodated in the pocket defined by Phe174, Tyr99 and Trp215. Also, the best model arises when the conformation of the Glu97 side chain is modified such that an H-bond interaction is maintained with the inhibitor if possible. The model also shows a tightening of the S1 pocket as is shown in the recent data described above.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stubbs, M.T. and Bode, W., Curr. Opin. Struct. Biol., 4 (1994) 823.
Claeson, G., Blood Coagul. Fibrinolysis, 5 (1994) 411.
Kelly, A.B., Maraganore, J.M., Bourdon, P., Hanson, S.R. and Harker, L.A., Proc. Natl. Acad. Sci. USA, 89 (1992) 6040.
Furie, B. and Furie, B.C., Cell, 53 (1988) 505.
Padmanabhan, K., Padmanabhan, K.P., Tulinsky, A., Park, C.H., Bode, W., Huber, R., Blankenship, D.T., Cardin, A.C. and Kisiel, W., J. Mol. Biol., 232 (1993) 947.
Blankenship, D.T., Brankamp, R.G., Manley, G.D. and Cardin, A.D., Biochem. Biophys. Res. Commun., 166 (1990) 1384.
Katakura, S., Nagahara, T., Hara, T., Kunitada, S. and Iwamoto, M., Eur. J. Med. Chem., 30 (1995) 387.
Lin, Z. and Johnson, M.E., FEBS Lett., 370 (1995) 1.
Stubbs, M.T., Huber, R. and Bode, W., FEBS Lett., 375 (1995) 103.
Nagahara, T., Yokoyama, Y., Inamura, K., Katakura, S., Komoriya, S., Yamaguchi, H., Hara, T. and Iwamoto, M., J.Med. Chem., 37 (1994) 1200.
Diana, G.D., Kowalczyk, P., Treasurywala, A.M., Oglesby, R.C., Pevear, D.C. and Dutko, F.J., J. Med. Chem., 35 (1992) 1002.
Waller, C.L., Oprea, T.I., Giolitti, A. and Marshall, G.R., J. Med. Chem., 36 (1993) 4152.
Cho, S.J., Serrano, M.G., Bier, J. and Tropsha, A., J. Med. Chem., 39 (1996) 5064.
Cramer III, R.D., Patterson, D.E. and Bunce, J.D., J. Am. Chem. Soc., 110 (1988) 5959.
Cramer III, R.D., DePriest, S.A., Patterson, D.E. and Hecht, P., In Kubinyi, H. (Ed.), 3D QSAR in Drug Design: Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993, pp. 443–455.
Clark, M. and Cramer, R.D., Quant. Struct.–Act. Relatsh., 12 (1993) 137.
Böhm, H.J., J. Comput.-Aided Mol. Design, 8 (1994) 623.
Kuntz, I.D., Meng, E.C. and Shoichet, B.K., Acc. Chem. Res., 27 (1994) 117.
Miller, M.D., Kearsley, S.K., Underwood, D.J. and Sheridan, R.P., J. Comput.-Aided. Mol. Design, 8 (1994) 153.
Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer, E.F., Brice, M.D., Rodgers, J.R., Kennard, O., Shimanouchi, T. and Tasumi, M., J. Mol. Biol., 112 (1977) 535.
SYBYL6.22, a molecular modeling system is supplied by Tripos Assoc., St. Louis, MO.
Weiner, S.J., Kollman, P.A., Case, D.A., Singh, U.C., Ghio, C., Alagona, G., Profeta, S. and Weiner, P., J. Am. Chem. Soc., 106 (1984) 765.
Clark, M., Cramer III, R.D. and Van Opdenbosch, N., J. Comput. Chem., 10 (1989) 982.
Greer, J., J. Mol. Biol., 153 (1981) 1027.
Greer, J., J. Mol. Biol., 153 (1981) 1043.
Stewart, J.J.P., MOPAC, Version 5.0, a semi-empirical program supplied by QCPE (No. 455), Indiana University, Bloomington, IN, 1989.
Katakura, S., Nagahara, T., Hara, T. and Iwamoto, M., Biochem. Biophys. Res. Commun., 197 (1993) 965.
Brandstetter, H., Kuhne, A., Bode, W., Huber, R., von der Saal, W., Wirthensohn, K. and Engh, R.A., J. Biol. Chem., 271 (1996) 29988.
Allen, F.H., Davies, J.E., Galloy, J.J., Johnson, O., Kennard, O., Macrae, C.F., Mitchell, E.M., Mitchell, G.F., Smith, J.M. and Watson, D.G., J. Chem. Inf. Comput. Sci., 31 (1991) 187.
Learch, A.R., In Lipkowitz, K.B. and Boyd, D.B. (Eds.), Reviews in Computational Chemistry, Vol. II, VCH Publishers, New York, NY, 1991, pp. 1–55.
Höltje, H.-D. and Folkers, G., Molecular Modeling, Basic Principles and Applications (Methods and Principles in Medicinal Chemistry, Vol. 5), VCH, Weinheim, 1997, pp. 25–28.
Beusen, D.D., Berkley Shands, E.F., Karasek, S.F., Marshall, G.R. and Dammkoehler, R.A., J. Mol. Struct. (THEOCHEM), 370 (1996) 157.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaz, R.J., McLean, L.R. & Pelton, J.T. Evaluation of proposed modes of binding of (2S)-2-[4-[[(3S)-1-acetimidoyl-3-pyrrolidinyl]oxy]phenyl]-3-(7-amidino-2-naphthyl)propanoic acid hydrochloride and some analogs to Factor Xa using a comparative molecular field analysis. J Comput Aided Mol Des 12, 99–110 (1998). https://doi.org/10.1023/A:1007969517376
Issue Date:
DOI: https://doi.org/10.1023/A:1007969517376